Clover Biopharmaceuticals, Ltd.
HKEX:2197.HK
1.57 (HKD) • At close September 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2020 Q4 | 2020 Q2 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 401.243 | 458.774 | 735.864 | 1,264.455 | 1,607.409 | 2,255.642 | 2,767.371 | 516.184 | 332.439 | 148.694 |
| Short Term Investments
| 26.284 | 7.943 | 30.393 | 34.105 | 33.172 | 27.075 | 98.796 | 290.328 | 150.164 | 10 |
| Cash and Short Term Investments
| 427.527 | 480.971 | 766.257 | 1,298.56 | 1,640.581 | 2,282.717 | 2,866.167 | 806.512 | 482.603 | 158.694 |
| Net Receivables
| 45.638 | 0.004 | 24.106 | 0.581 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 11.031 | 696.733 | 696.978 | 1,169.058 | 2,384.34 | 1,536.471 | 768.691 | 50.881 | 25.637 | 0.393 |
| Other Current Assets
| 179.013 | 436.629 | 425.463 | 353.49 | 381.308 | 1,075.432 | 0 | 191.032 | 98.146 | 5.259 |
| Total Current Assets
| 663.209 | 1,614.337 | 1,899.519 | 2,805.56 | 4,389.929 | 4,894.62 | 5,076.495 | 1,048.425 | 606.386 | 164.346 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 116.181 | 146.189 | 162.056 | 219.036 | 241.744 | 245.303 | 222.403 | 86.987 | 52.208 | 17.428 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 33.354 | 36.745 | 39.859 | 36.192 | 34.998 | 25.164 | 13.828 | 0.277 | 0.286 | 0.294 |
| Goodwill and Intangible Assets
| 33.354 | 36.745 | 39.859 | 36.192 | 34.998 | 25.164 | 13.828 | 0.277 | 0.286 | 0.294 |
| Long Term Investments
| 0 | 0 | -14.165 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 14.165 | 18.257 | 28.035 | 47.916 | 32.934 | 51.839 | 27.994 | 4.148 |
| Total Non-Current Assets
| 149.535 | 182.934 | 201.915 | 273.485 | 304.777 | 318.383 | 269.165 | 139.103 | 80.487 | 21.87 |
| Total Assets
| 812.744 | 1,797.271 | 2,101.434 | 3,079.045 | 4,694.706 | 5,213.003 | 5,345.66 | 1,187.528 | 686.872 | 186.216 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 120.453 | 181.233 | 247.829 | 226.378 | 856.964 | 970.733 | 588.559 | 33.82 | 20.493 | 7.165 |
| Short Term Debt
| 86.149 | 225.004 | 326.598 | 433.791 | 317.63 | 26.089 | 21.48 | 4.259 | 3.035 | 1.81 |
| Tax Payables
| 1.097 | 0 | 3.067 | 0 | 6.284 | 0 | 5.919 | 1.422 | 0.753 | 0.083 |
| Deferred Revenue
| 0 | 0 | 1,702.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 1,699.964 | 1,667.009 | -2.542 | 1,707.144 | 1,648.327 | 1,612.777 | 1,532.151 | 27.233 | 22.831 | 18.429 |
| Total Current Liabilities
| 1,907.663 | 2,073.246 | 2,277.003 | 2,367.313 | 2,829.205 | 2,609.599 | 2,148.109 | 66.734 | 47.111 | 27.487 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 3.495 | 6.096 | 7.853 | 22.152 | 36.738 | 54.127 | 46.44 | 18.057 | 14.351 | 10.645 |
| Deferred Revenue Non-Current
| 0 | 0 | 44.364 | 145.776 | 2,496.9 | 2,372.691 | 1,931.963 | 958.172 | 487.671 | 17.17 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -44.364 | 0 | -2,496.9 | -2,372.691 | -1,931.963 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 537.884 | 550.704 | 549.411 | 661.027 | 0 | 0 | 1,931.963 | 1,127.306 | 671.606 | 215.906 |
| Total Non-Current Liabilities
| 541.379 | 556.8 | 557.264 | 683.179 | 2,533.638 | 2,426.818 | 1,978.403 | 2,103.535 | 1,165.043 | 226.551 |
| Total Liabilities
| 2,449.042 | 2,630.046 | 2,834.267 | 3,050.492 | 5,362.843 | 5,036.417 | 4,126.512 | 2,170.269 | 1,212.154 | 254.038 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 9,640.268 | 0 | 0 | 0 | 6,753.194 | 0 | 0 | 0 |
| Common Stock
| 0.838 | 0.838 | 0.838 | 0.836 | 0.835 | 0.744 | 0.742 | 0 | 0 | 0 |
| Retained Earnings
| 0 | -9,735.391 | -9,640.268 | -8,851.105 | -9,501.729 | -8,185.911 | -7,049.826 | -1,033.523 | -577.074 | -120.625 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 265.818 | -733.641 | 290.218 | 270.383 | 301.321 | 296.632 | 50.782 | 51.792 | 52.803 |
| Other Total Stockholders Equity
| -1,637.136 | 8,635.96 | 8,906.597 | 8,588.604 | 8,832.757 | 8,060.432 | 7,971.6 | 0 | 0 | 0 |
| Total Shareholders Equity
| -1,636.298 | -832.775 | -732.833 | 28.553 | -668.137 | 176.586 | 1,219.148 | -982.741 | -525.282 | -67.822 |
| Total Equity
| -1,636.298 | -832.775 | -732.833 | 28.553 | -668.137 | 176.586 | 1,219.148 | -982.741 | -525.282 | -67.822 |
| Total Liabilities & Shareholders Equity
| 812.744 | 1,797.271 | 2,101.434 | 3,079.045 | 4,694.706 | 5,213.003 | 5,345.66 | 1,187.528 | 686.872 | 186.216 |